Philip Kantoff

Independent Director

Dr. Kantoff has served as a member of the board of directors since December of 2018. Dr. Kantoff is the Co-Founder and Chief Executive Officer of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharmaceutical therapies for prostate and other cancers. Previously, Dr. Kantoff served as th...

Roles at Context Therapeutics

  • Independent Director

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Context Therapeutics

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.